The MHRA is seeking views on the proposed changes to the UK Human Medicines Regulations 2012 (Human Medicines Regulations 2012). The proposed POC framework is specifically designed to create and regulate a step change in the range of manufacturing options to enable the supply and increase the availability of innovative new medicinal products to patients. This new manufacturing and supply system in the UK healthcare system will benefit patients that currently have no or few treatment options by improving the availability of innovative medicines.
Point of Care Consultation - GOV.UK (www.gov.uk), and the response form can be accessed here:
UK Government response to the UK-wide consultation on proposals to support the regulation of medicines manufactured at Point of Care (POC).